Summary. The effects of exotoxin A (EXA) from Pseudomonas aeruginosa on polymorphonuclear leucocytes (PMNLs) were studied in a mouse model and in vitro. P. aeruginosa PA103, which produced EXA, was 20 times more virulent for normal mice than was its EXAdeficient mutant, PA103-29. EXA was detected in the plasma of mice infected with P. aeruginosa PA103, and its presence correlated with increasing numbers of bacteria in the blood and internal organs. A monoclonal antibody (MAb) against EXA prevented the death of the mice if it was given simultaneously with, or 2 h before, infection with strain PA103. The number of PMNLs in murine blood decreased by 50 YO within 30 min of intravenous injection of EXA, but this decrease was prevented by simultaneous or prior injection of MAb to the toxin. EXA inhibited in-vitro phagocytosis and killing of P. aeruginosa by human and murine PMNLs and decreased the number of the PMNLs by between 60 and 68 YO. Collectively, these results not only confirm that EXA is toxic in uivo, but also suggest that this toxin accelerates the growth of virulent P. aeruginosa in mice.
Introduction
Pseudomonas aeruginosa is a significant cause of nosocomical infection and has a capacity for tissue invasion, often leading to septicaemia and death. Mortality rate in pseudomonas bacteraemias are higher than in bacteraemias caused by most other gram-negative opportunist ~a t h 0 g e n s . l~~ Exotoxin A (EXA) is a major toxic product of P. aeruginosa and contributes to mortality in experimental animals and patients. Its mechanism of action against mammalian cells has been studied in There are reports that the survival rate among patients with antibodies to EXA or the lipopolysaccharide (LPS) of P. aeruginosa, or both, are higher than those of patients without these Moreover, it has been reported that 80% of P. aeruginosa isolates from infections produce EXA and that the mortality rate among patients infected with isolate producing EXA is three times higher than that among patients infected by non-pr0ducers. l We hypothesised that EXA might cause a decrease in the numbers of polymorphonuclear leucocytes (PMNLs), or a disturbance of their function, and that this might accelerate the proliferation of the bacteria, increasing the likelihood of death. To clarify the action of EXA on PMNLs, the changes in bacterial numbers in the blood and internal organs of mice inoculated intraperitoneally with an EXA-producing strain of P. aeruginosa or with its EXA-deficient mutant were examined. In addition, the effects of EXA on the function of PMNLs were examined in vitro and in vivo. Finally, the effect of a neutralising antibody, MAb 3C7,I2 on the in-vivo and in-vitro actions of EXA on PMNLs was investigated.
Materials and methods
Organisms P. aeruginosa PA103, which is virulent for mice, and its non-virulent derivative, PA103-29, were a gift from Dr Igrewski. Both were stored at -80°C in skimmed milk 20 YO.
Exotoxin A (EXA)
Pseudomonas EXA was purchased from the Swiss Serum and Vaccine Institute (Berne, Switzerland). It was > 97% pure and was free of LPS.
Mouse monoclonal antibodies (MAbs)
MAb 3C7 (IgGl), which binds to EXA, was a gift from the Research Laboratories of Sumitomo Pharmaceuticals Ltd (Osaka, Japan). MAb 1 B5 (IgG3), to an outer-membrane component of Haemophilus influenzae, was prepared by Dr T. Matsumoto in this laboratory (unpublished).
An inids
Four week-old male ICR mice, weighing 18-20 g (Japanese Charles fiver, Atsugi, Japan) were used in groups of 10, unless otherwise indicated. Leucopenia was induced by treatment with a single intraperitoneal (imp.) dose of cyclophosphamide (Sigma) of 250 mg/kg, given 4 days before bacterial ~ha1lenge.l~
Pwpuration of inoculu for infection
Bacteria were cultured overnight on Nutrient Agar (Difco) at 35"C, then harvested, washed twice and resuspended in saline to an OD660 of 0.2, corresponding to c. 3 x lo8 cfu/ml. Doubling dilutions of this suspension were employed for i.p. injection. To confirm the inoculum size, plate counts were determined in duplicate on serial dilutions of the suspensions.'4
LD.50 determinations
Mice were challenged with a single i.p. injection of 0-5 ml of the bacterial suspension. Eight dilutions, containing different numbers of viable bacteria, were used to determine LD50 values, and mortality was assessed daily for 5 days after infection.
Protection by MAb to EXA against P. aeruginosa infection in mice
The method of Kohzuki et al. was followed. 15 Groups of mice were given MAb 3C7 intravenously (i.v.) at a dose of 10pg/mouse either simultaneously with, 2 h before or 2 h after, infection with 1.5 x lo6 cfu/mouse of P. aeruginosa cells. A control group of mice was challenged with the same inoculum of bacteria but without MAb 3C7.
Quantitation of bacteria in mice and estimation of E X A and LPS
Mice, in groups of five, were challenged by i.p. injection with 0.5-ml portions of bacterial suspensions. The challenge dose was 1.6 x lo7 cfu/mouse of the virulent strain PA103 or 1.3 x 10' cfu/mouse of the avirulent strain PA103-29. Samples were obtained at 2,4 and 6 h after infection; the mice were anaesthetised with diethyl ether. Blood was obtained by heart puncture with a disposable heparinised syringe and, simultaneously, the liver, spleen, kidneys and lung were removed, homogenised (Homogenizer, Hongoikakikai, Tokyo, Japan) and diluted in saline. The samples and their dilutions were plated in duplicate on nutrient agar for viable counts.I4 Portions of the blood samples also were centrifuged, and the supernates were assayed for EXA and LPS. EXA was measured by ELISA (according to Kohzuki et al.15) , which has a lower detection limit of 2 ng/ml, and LPS was assayed by the chromogenic Limulus test (Toxicolor system; Seikagaku Co., Tokyo, Japan),16 which has a lower detection limit of 0-3 ng/ml.
Influence of purijied EXA on PMNLs
Mice, in groups of five, were inoculated i.v. with either 0-1 ml of EXA 1 pg/ml in saline or with a mixture containing EXA 1 pg/ml plus either MAb 3C7 or MAb 1B5 100 ,ug/ml, At 0*5,1,2 and 24 h after injection, the mice were lightly anaesthetised with diethyl ether and 30-pl samples of blood were removed from the retro-orbital plexus with disposable, heparinised, capillary tubes. These samples were stained with Turk solution for determination of white blood cell numbers or with May-Grunwald-Giemsa stain for PMNL counts.
Interactions of PMNLs and EXA in vitro
Mouse PMNLs were prepared as described elsewhere,17 and suspended at a density of 1.0 x 107/ml in Eagle's Minimal Essential Medium (MEM ; Gibco Laboratories, Grand Island, NY, USA). Human PMNLs were purified from human peripheral blood by Hypaque-Ficoll (Flow Laboratories, Irvine)18 and resuspended in MEM at the same density as the mouse PMNLs. A 0.1-ml-portion of EXA solution, 2 pg/ml in MEM, with or without MAb 3C7 at 200 pg/ml, was added to 0.9 ml of the human or mouse PMNLs and the mixture was rotated at 5 rpm for 1 h at 35°C. One ml of bacterial suspension (1.0 x lo6 cfulml) in MEM, containing fresh human or mouse serum lo%, was then added, and after rotation for a further 2 h, each sample was plated in duplicate on nutrient agar for viable
In addition, the PMNLs were counted in a haemocytometer and their morphology was examined by microscopy after staining by the MayGriinwald-Giemsa method.
Data analysis
The LD50 of the bacteria was calculated by probit analysis from the survival rates of the mice after 5 days of infection.lg Numbers of organisms and PMNLs in different groups of animals were compared by Student's t test.
Results

Virulence of P. aeruginosa PA103 and PA103-29 in mice
The LD5Os of P aeruginosa PA103 and PA103-29 in normal mice were 6-82 x lo5 and 1-36 x lo7 cfu/mouse, Time after infection (h) respectively, whereas those in neutropenic mice were 8-40 x lo3 and 6.03 x lo6, respectively ( fig. 1) . Thus, the virulence of P. aeruginosa PA103 in the neutropenic mice was 151-fold greater than in normal mice, whereas the virulence of P. aeruginosa PA103-29 was only double that in normal mice. Normal and neutropenic mice infected with P. aeruginosa PA103 died between 1 and 4 days after infection, whereas deaths among mice infected with strain PA 103-29 occurred only on the first 2 days after infection. When MAb 3C7 was given simultaneously with, or 2 h before, infection with 1-50 x lo6 cfu/mouse of P. aeruyinosa PA103, the survival rates of the mice were 70 ' / o and 80 YO, respectively. However, only 40 YO of the mice survived when the antibody was given 2 h post-infection, no more than when the mice were not given the antibody.
Localisation of bacteria in infected mice
The bacterial numbers in blood samples taken at various times after infection were examined. At 2 and 4 h after infection, the mean numbers of P . aeruginosa PA103-29 cells were more than those of P . aeruginosa PA103, reflecting the fact that the challenge dose of the former, avirulent, organism was about 10-fold greater than that of the latter, virulent, strain ( fig. 2) . However, by 6 h after infection the mean bacterial numbers in the blood of mice infected with P. aeruginosa PA103 were > 10-fold greater than those from mice infected Bacterial numbers in the liver, lungs, spleen and kidneys were also examined ( fig. 3) . At 2 h after infection, the mean bacterial counts from the livers of mice infected with P . aeruginosa PA103 were significantly (p < 0-05) greater than in those of mice infected with P. aeruginosa PA103-29 (fig. 3b) . P . aeruginosa PA 103 proliferated rapidly, reaching c. l O5 cfu/g in all tissues examined by 4 h after infection, but with little further change by 6 h after infection. However, with P . aeruginosa PA103-29, the number of organisms in each organ peaked around 4 h after infection, at c. lo4 cfu/g, and tended to decline over the next 2 h, especially in the spleen and kidneys where the counts at 6 h reduced to lo2 cfu/g of tissue ( fig.  3c,d ). These 6-h counts were significantly below those recorded in mice infected with P . aeruginosa PA103 (p < 0.01).
Concentrations of EXA and LPS in plasma
Only one of five mice infected with strain PA103 had a measurable EXA level at 2 h after infection ( fig. 4a ), but four of five infected mice had measurable levels by 6 h after infection, ranging from 6-9 to 13 ng/ml. EXA was not detected in mice infected with P . aeruginosa PA103-29. The plasma concentrations of LPS were almost identical in mice infected with either P . aeruginosa PA103 or its mutant by 6 h after infection ( fig. 4b) .
The efects of EXA on PMNLs in vivo
. The mean number of PMNLs in blood from normal mice was 1420 (SD 117) cells/mm3, but this was significantly reduced (p < 0.05) by 0.5-2 h after injection of EXA alone (fig. 5 ). This reduction did not occur in mice given a mixture of EXA and the homologous antibody MAb 3C7, but was still observed when EXA was given with the non-homologous antibody, MAb 1B5. No significant differences in the numbers of PMNLs in the blood remained by 24 h after injection of EXA.
Efect of EXA on bacterial phagocytosis and killing by PMNLs
When P . aeruginosa PA103 cells, at an initial density of 5 x lo5, were incubated for 2 h with fresh human serum, with or without human PMNLs, the bacterial counts were 1-82 x lo4 and 4-79 x lo5, respectively (table I). Addition of EXA reduced the extent of bacterial killing by the PMNLs, but killing was partially regained if MAb 3C7 was also added. P . aeruginosa PA103-29 was also killed by human PMNLs and, once again, this killing was reduced if EXA was added (p < O-Ol), but substantially recovered when MAb 3C7 also was present (p < 0.01).
The decreases in bacterial numbers achieved by murine PMNLs in murine serum were smaller than those obtained by human PMNLs in human serum, but the pattern of the results was almost identical. After incubation with serum-treated bacteria and EXA for 2 h, the numbers of human and murine PMNLs were decreased to 60% and 68 YO of their starting numbers, respectively. The destroyed PMNLs, and their swollen nuclei, were observed by microscopy after staining by the May-Griinwald-Giemsa method. corresponding toxigenic parent strains, PA 103 and PAO-1. In the case of strain PA103-29, EXA was absent, or produced at a vastly lower level, than in strain PA103." It is well known that EXA inhibits protein synthesis in mammalian cells by transferring the ADP-ribose moiety of NAD' to elongation factor 11, leading to tissue damage and cell death.12 EXA is one of the most powerful exotoxins of P. aeruginosa' and levels o f antibody to EXA were higher in patients who survived P . aeruginosa bacteraemias than in those who died of their infection.' Pollack and Young5
Discussion
The present study confirmed that the virulence of P. aeruginosa PA103 was greater than that of strain PA103-29 in both normal and neutropenic mice. Mice infected with strain PA103-29 only died if at all from bacteraemia within 2 days, whereas those infected with strain PA103 died in greater numbers not only within the first 2 days but also later. The presence of neutropenia enhanced the virulence of P . aeruginosa PA103 much more than that of P. aeruginosa PA103-29. This result concurs with the higher mortality rate for infections caused by EXA-producing P . aeruginosa showed that the amount of antibody to EXA correlated well with the survival rate among patients with P. aeruginosa bacteraemia.
strains in patients with leucopenia than in those without this condition.' The greater virulence of P.
aeruginosa PA103 seems likely to be due to the in-vivo production of EXA itself, considering that production of this toxin is the main difference from strain We postulated that the greater virulence of strain PA103 might involve the action of EXA against PMNLs. EXA decreased the number of murine PMNLs in vivo, 21 and killed murine and human PMNLs in vitro. Also, EXA inhibited the phagocytosis and killing of P. aeruginosa cells by PMNLs in vitro. Administration of MAb 3C7 antibodies against EXA inhibited the decrease in PMNL numbers caused by EXA in vivo and prevented death of the mice, whereas the non-homologous antibody, MAb 1B5, had no effect. Kohzuki et a l l 5 reported previously that administration of MAb 3C7 did not protect mice against bacteraemic death caused by P. aeruginosa 103. However, these authors only gave the antibody 2 h post-infection and, as the present study showed, protection against killing required that MAb 3C7 PA 103-29.
